Sustained Growth Hormone Signaling
CJC-1295 with DAC (Drug Affinity Complex) is a long-acting analogue of growth hormone–releasing hormone (GHRH). Designed for extended half-life and prolonged receptor interaction, it stimulates endogenous growth hormone release in a sustained manner.
Unlike direct hormone replacement, CJC-1295 activates upstream signaling — supporting physiologic GH production while maintaining natural regulatory patterns.
Functional Focus
Endogenous GH Stimulation
Promotes the body’s own growth hormone release through GHRH receptor activation.
Extended Activity Profile
DAC modification allows for prolonged circulation and sustained signaling.
Lean Mass Support
Studied for its association with muscle maintenance and body composition refinement.
Recovery + Repair
GH pathway activation may support tissue regeneration and structural recovery.
Sleep + Hormonal Rhythm
Influences natural pulsatile growth hormone dynamics tied to circadian cycles.
Research Notes
CJC-1295 with DAC is investigational and not FDA approved for anti-aging or performance enhancement. Its use is limited to laboratory research settings unless prescribed under medical supervision.
This compound is intended for research purposes only.